Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Next-Generation Roche: How Data Analytics Will Keep It In The Lead In Oncology

Jun 08 2018

• By Mary Jo Laffler

DNA

Related Content

'Watch This Space' Roche Execs Say, Outlining RWE Rationale For Flatiron Buy

Apr 26 2018

Gottlieb Uses ASCO Platform To Unveil Two Pilot Programs To Speed Drug Review

Jun 03 2018

Real World Evidence Benefits, Limits Explored In US FDA Demonstrations

Oct 30 2017

Roche, Bristol On The Defensive After Merck's Lung Cancer Wins At ASCO

Jun 06 2018

Pharma trial needs drive Roche's $1.2bn Foundation Medicine deal

Jan 12 2015

Roche To Build RWE Cancer Data Extraction Role With Flatiron Buy

Feb 19 2018

Roche Pushes The Boundaries Of Cancer Immunotherapy

Jun 09 2017

Roche’s Alecensa Goes Up Against Zykadia with First-Line NSCLC US FDA Approval

Nov 07 2017

Roche's Oncology Strategy: The Long Game Comes Into Focus

Jun 15 2015

Roche R&D Operations Controlled By 'Go … Wait … Or Gate'

Nov 16 2015

Roche Could Repeat Genentech Success With Foundation Medicine Partnership

Jan 12 2015

How The EHR And New Data Streams Are Influencing Clinical Practice

Jun 13 2018

Roche's Guide To Success In Oncology

Jun 27 2016

Related Companies

Roche Holding AG

Foundation Medicine, Inc.

Roche Holding AG

Additional Topics

Digital Health Innovation Clinical Trials Companies ImmunoOncology Market Access Regulation Artificial Intelligence Business Strategies Reimbursement Research & Development Strategy ASCO BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window